Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
101.76m
Last Price
$3.1899
52-Week Range
$2.75 - $5.13
04/26/2024 12:42 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808